Article
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
2022-06-28
Abstract excerpt
<h4>ABSTRACT</h4> As the SARS-CoV-2 pandemic remains uncontrolled owing to the continuous emergence of variants of concern, there is an immediate need to implement the most effective antiviral treatment strategies, especially for risk groups. Here, we evaluated the therapeutic potency of nirmatrelvir, remdesivir, and molnupiravir and their combinations in SARS-CoV-2-infected K18-hACE2 transgenic mice. Systemic tr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9bec2510-1437-5416-b4f2-6a7b17e11e3f
- DOI
- 10.1101/2022.06.27.497875
